Search research articles
Contact Us
Filters
Showing results (91-100 of 362) with videos related to
Page
of 37
Sort By:
Nature Reviews. Clinical Oncology
|
August 15, 2025
Treatment of NSCLC after chemoimmunotherapy - are we making headway?
Martin Reck, Nikolaj Frost, Solange Peters, et al.
Frontiers in Oncology
|
July 5, 2021
Lurbinectedin in Refractory Diffuse Malignant Peritoneal Mesothelioma: Report of Two Cases
Louis Gros, Petr Szturz, Antonella Diciolla, et al.
Journal for Immunotherapy of Cancer
|
June 28, 2023
Cytokine storm complicated by cardiogenic shock induced by anti-HER2 therapies
Rita Godinho, Alessandra Noto, Craig Fenwick, et al.
Revue Medicale Suisse
|
May 18, 2022
[Targeted therapies and non-small cell carcinomas : novelties]
Roberta Stauber, Louis Gro S, Tu Nguyen-Ngoc, et al.
Revue Medicale Suisse
|
May 16, 2019
[The new management options for lung cancer in the immunotherapy era]
Heyfa Meganem, Roxana-Maria Socianu, Hasna Bouchaab, et al.
Melanoma Research
|
September 5, 2014
Dramatic response of vemurafenib-induced cutaneous lesions upon switch to dual BRAF/MEK inhibition in a metastatic melanoma patient
Solange Peters, Hasna Bouchaab, Stefan Zimmerman, et al.
Cancer Cell
|
May 27, 2020
The COVID-19 and Cancer Consortium: A Collaborative Effort to Understand the Effects of COVID-19 on Patients with Cancer
Samuel M Rubinstein, John A Steinharter, Jeremy Warner, et al.
Lung Cancer (Amsterdam, Netherlands)
|
February 6, 2013
A dramatic lung cancer course in a patient with a rare EGFR germline mutation exon 21 V843I: Is EGFR TKI resistance predictable?
Nadine Demierre, Vincent Zoete, Olivier Michielin, et al.
Cancer Treatment Reviews
|
February 8, 2022
Efficacy of targeted therapies for oncogene-driven lung cancer in early single-arm versus late phase randomized clinical trials: A comparative analysis
Aaron C Tan, Sze Huey Tan, Siqin Zhou, et al.
Lung Cancer (Amsterdam, Netherlands)
|
December 23, 2023
Face to face among different chemo-immunotherapy combinations in the first line treatment of patients with advanced non-small cell lung cancer: Results of an international expert panel meeting by the italian association of thoracic oncology (AIOT)
Cesare Gridelli, Solange Peters, Tony Mok, et al.
Page
of 37
Search research articles
Search
Showing results (91-100 of 362) with videos related to
Sort By:
Page
of 37
Nature Reviews. Clinical Oncology
|
August 15, 2025
Treatment of NSCLC after chemoimmunotherapy - are we making headway?
Martin Reck, Nikolaj Frost, Solange Peters, et al.
Frontiers in Oncology
|
July 5, 2021
Lurbinectedin in Refractory Diffuse Malignant Peritoneal Mesothelioma: Report of Two Cases
Louis Gros, Petr Szturz, Antonella Diciolla, et al.
Journal for Immunotherapy of Cancer
|
June 28, 2023
Cytokine storm complicated by cardiogenic shock induced by anti-HER2 therapies
Rita Godinho, Alessandra Noto, Craig Fenwick, et al.
Revue Medicale Suisse
|
May 18, 2022
[Targeted therapies and non-small cell carcinomas : novelties]
Roberta Stauber, Louis Gro S, Tu Nguyen-Ngoc, et al.
Revue Medicale Suisse
|
May 16, 2019
[The new management options for lung cancer in the immunotherapy era]
Heyfa Meganem, Roxana-Maria Socianu, Hasna Bouchaab, et al.
Melanoma Research
|
September 5, 2014
Dramatic response of vemurafenib-induced cutaneous lesions upon switch to dual BRAF/MEK inhibition in a metastatic melanoma patient
Solange Peters, Hasna Bouchaab, Stefan Zimmerman, et al.
Cancer Cell
|
May 27, 2020
The COVID-19 and Cancer Consortium: A Collaborative Effort to Understand the Effects of COVID-19 on Patients with Cancer
Samuel M Rubinstein, John A Steinharter, Jeremy Warner, et al.
Lung Cancer (Amsterdam, Netherlands)
|
February 6, 2013
A dramatic lung cancer course in a patient with a rare EGFR germline mutation exon 21 V843I: Is EGFR TKI resistance predictable?
Nadine Demierre, Vincent Zoete, Olivier Michielin, et al.
Cancer Treatment Reviews
|
February 8, 2022
Efficacy of targeted therapies for oncogene-driven lung cancer in early single-arm versus late phase randomized clinical trials: A comparative analysis
Aaron C Tan, Sze Huey Tan, Siqin Zhou, et al.
Lung Cancer (Amsterdam, Netherlands)
|
December 23, 2023
Face to face among different chemo-immunotherapy combinations in the first line treatment of patients with advanced non-small cell lung cancer: Results of an international expert panel meeting by the italian association of thoracic oncology (AIOT)
Cesare Gridelli, Solange Peters, Tony Mok, et al.
Page
of 37